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ETIOPATHOLOGY OF AUTOIMMUNE DISEASE 
AND DENTAL PERSPECTIVES 
 
MELISSA SEIF 
 
ABSTRACT 	  
The main and most critical function of the immune system is to distinguish 
between self and non-self and react accordingly. Differentiating self-reactive 
immune cells as soon as they develop is the phenomenon of tolerance against 
self-antigens and is a highly regulated process. The development of 
autoantibodies is a sign of the breakdown of tolerance and may be the harbinger 
of the onset of an autoimmune disease.  
 
It is well-known fact that many systemic autoimmune diseases (AUIDs) first 
manifest in the oral cavity.  If proven that oral infections trigger AUIDs, then 
improving oral health may be a potential therapeutic strategy to reduce 
autoimmune disease incidence. Although etiology and pathogenesis of specific 
AUIDs may vary, presentation in the oral cavity often involves oral lesions 
manifested at early stages of systemic inflammatory and autoimmune disease. 
Therefore regular dental and medical checkups may provide an opportunity for 
clinicians, in particular dentists, to contribute to earlier detection of AUIDs thereby 
improving long-term treatment options and overall patient prognosis.  
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Mechanisms leading to the onset of autoimmune disease are still being 
considered. Epidemiological inquires and the increasing numbers of genome-
wide association studies have analyzed the breakdown of tolerance and the 
causes behind autoimmunity.  The role of the environment is crucial in the onset 
of autoimmunity via the breakdown of tolerance; through toll-like receptors that 
mediate innate immunity which in turn triggers the adaptive autoimmune 
response, T regulatory cells and Th17 differentiation, through changes in the 
spleen autoantibody production due to a change in the B cell count, and through 
self antigen and epigenetic deviations induced by environmental spurs. In spite of 
many research efforts and the accumulation of innovative data, there are still 
multiple gaps in knowledge pertaining to this subject matter.  
 
The autoimmune process begins with the activation of Tcells by antigen 
presenting cells (APC) and progresses to CD4+ CD25+ Tcells and forkhead box 
P3 (Foxp3), which stimulate Th1 and Th2 responses and finally B cell activation, 
which plays a role in autoimmune development. This paper will review the 
etiopathogenesis of autoimmune diseases and different cell players as well as 
transcription factors such as TGF-β, IL-6, IL-10, IL-17, Th-17, T reg cells, B reg 
cells, Th-1, Th-2, and INF-ɤ.  
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This paper aims to review published evidence and further explore the 
etiopathology of individual autoimmune diseases such as Behcet’s, Crohn’s 
disease, Sjögren syndrome, systemic lupus erythematosus, and rheumatoid 
arthritis and the subsequent dental implications and therapeutic management. 
This review also aims to study the most relevant autoimmune, auto-inflammatory, 
and systemic chronic inflammatory diseases, as well as mechanisms of 
autoimmune manifestation with respect to oral health.  
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INTRODUCTION 
 
Epidemiology is the study of distribution of patterns, causes, and effects 
of disease within a population. It is basically identifying risk factors for a certain 
disease and targets for preventative healthcare (Walsh et al. 2000). Studying the 
epidemiology of autoimmune diseases indicates that these diseases have a 
diverse demographic profile with the common factor that is their impairment to 
tissues and organs that result from the response to self-antigens (Cooper et al. 
2009).  
 
Autoimmunity is described as the failure of an organism in recognizing self, 
where a misdirected immune response is initiated against the organism’s own 
cells. It is characterized by a trigger of both the adaptive and immune systems in 
the failure of distinguishing “self” from “nonself”. This is evidenced by the 
existence of autoantibodies and T lymphocytes responsive to host antigens. 
Autoimmunity when progressed from a benign to a pathogenic response due to 
both environmental influences and genetic predispositions, to result in a wide 
range of illnesses, is defined as autoimmune disease (Lleo et al. 2010; 
Romagnani 2000).  
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Innate and Adaptive Immune Systems 
 
The adaptive and innate immune systems are both players in fighting external 
microbes entering the body. The innate system is a series of non-specific 
responses that trigger the release of chemokines and cytokines (Si-Tahar et al. 
2009). It is the primary defense mechanism in the protection from pathogens; it 
functions through a network of systems that includes the recognition of pathogen-
associated molecular patterns (PAMPs) present on pathogens surface via 
pattern recognition receptors (PRRs). This system allows for rapid screening and 
determination of “self” from “non-self” and initiates quick immune responses 
accordingly.  
 
Toll-like receptors (TLRs) are a family of PRRs, which recognize PAMPs trait of 
pathogenic microorganisms (Selmi et al. 2012).  TLRs have a major role in the 
interaction of innate and adaptive immune responses. According to Selmi et al. 
recent studies have suggested an association between TLRs and autoimmune 
disease, where the hypothesis states that a distorted innate immune response as 
well as an altered TLR signal is a prominent step in the initiation of autoimmune 
disease (Selmi et al. 2012).  
 
The adaptive immune response recognizes pathogens based on memory and 
acts via T cells antigen presenting cells (APCs) and dendritic cells (Parija 2009). 
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Antibodies constitute a major part of acquired immunity (Selmi et al. 2012; Selmi 
2013). B lymphocytes (B cells) are responsible for antibody production and T 
lymphocytes (T cells) serve either as helper or regulatory cells.  
B lymphocytes are a large component of the adaptive immune system that 
generate their repertoire in the bone marrow through V(D)J recombination, which 
is characterized by the pairing of heavy and light chains to further increase 
diversity (Salinas et al. 2013; Selmi et al. 2012). During this combination some 
auto-reactive immunoglobulin (Ig) cannot be efficiently purged, however 
checkpoints in B cell development ensure that auto-reactive B lymphocytes are 
discounted, through deletion, receptor editing, or rendered anergic, from the 
peripheral lymphocyte population (Salinas et al. 2013). 
 
Autoimmune Diseases  
 
Autoimmune diseases occur when pattern recognition receptors (PRRs) fail in 
recognizing pathogen-associated molecular patterns (PAMPs) and erroneously 
identify a part of self as pathogens. This pathology as a group manifests an 
extensive variability in terms of age of onset, tissues targeted, and response to 
treatments suppressing the immune system. There are more than seventy 
distinctive autoimmune disorders affecting roughly five percent of Western 
populations (Mays et al. 2012). Autoimmune diseases are generally thought of as 
rare, however they are the leading causes of death among young and middle-
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aged women in the United States (Walsh et al. 2000). Of the many categories 
and different types of diseases, the most prevalent and the ones discussed 
mainly in this article include Behcet’s syndrome, Rheumatoid Arthritis (RA), 
Sjögren’s syndrome, Systemic Lupus Erythematosus, Multiple Sclerosis, and 
Crohn’s disease. 
 
Autoantibodies have been established as indicators of the presence of 
autoimmune occurrence; however, several studies have demonstrated that 
patients may carry autoantibodies for years before they manifest any clinical 
signs (Lleo et al. 2010). 
Behcet’s syndrome  
	  
Behcet’s is a chronic inflammatory disease that is characterized by ulcers in the 
oral mucosa as well as frequent muco-cutaneous lesions, defined by a yellowish 
necrotic base with a red rim surrounding (Mays et al. 2012). The symptomology 
can be more or less severe in different individuals and can result in serious 
issues such as meningitis, blood clots or issues with the central nervous system 
(Mendes et al. 2009) 
 
The etiology of Behcet’s disease is poorly defined, however, pathology of oral 
ulceration is evident. Tumor Necrosis Factor alpha (TNF-α) is involved in the 
pathogenesis as well as the recruitment of IL-12, IL-17 and IL-21 (Mendes et al. 
	  5	  	  
2009).  Most patients acquire hypersensitivity in the oral cavity and trigger an IL-
12 mediated delayed-type hypersensitivity response (Mays et al. 2012).    
Rheumatoid Arthritis 
	  
Rheumatoid arthritis (RA) is an autoimmune condition characterized for an 
increased number of autoantibodies and a hyper response to anti-TNFα. Recent 
advances employee B cell depleting treatments such as rituximab (Edwards, 
2004). RA is the one condition that demands for both clinical and basic evidence 
to be sought hand in hand in order to provide an ample understanding (Selmi 
2013). 
 
 Immunologically, it involves Rheumatoid factor, TNFα, IL-1, IL-6, and IL-17.  
Oral manifestations in RA are distinguished from other disease by the presence 
of periodontal disease (Mays et al. 2012). 
 
An experimental therapy study conducted on patients with RA consisted of 
treatment for 6 months with oral dnaJP1, epitope-specific immunotherapeutic 
molecule derived from heat shock proteins that initiate proinflammatory T cell 
responses in naïve RA patients, showed result of increased 
Foxp3+CD4+CD25+T cells (Chen et al .2002). These results suggest that 
treatment with an antibody against proinflammatory inducing peptide enhances T 
regulatory cell stimulation.  
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This study allows envisioning the feasibility of manipulating T regulatory cells for 
therapeutic advantages (Chen et al .2002; Nakamura et al. 2001). 
Sjögren’s Syndrome 
	  
 Sjögren’s syndrome is an autoimmune disease characterized by the destruction 
of salivary and lacrimal exocrine glands (Tapinos et al. 1999). It involves IL-6, IL-
12, IL-17 and IL-23, and is distinguished specifically by frequent caries, the 
presence of Xerostomia (Mavragani et al. 2006), and candidiasis. 
 
In Sjögren syndrome, Selmi et al. has demonstrated that memory B cells are 
quantitatively reduced in target organs. T cells have a large role in determining B 
cell activation, tolerance and B cell receptor (BCR) signaling, particularly in 
lupus-prone mice (Selmi et al. 2012).  
 
The major messengers that mediate inflammatory stimuli, tolerance and 
autoimmunity are cytokines. In autoimmune disease, targeting TNF-α elicits 
autoimmune manifestations, particularly in terms of antinuclear (ANA) and anti-
dsDNA antibodies (Atzeni et al. 2012). Cytokines such as IL-2, IL-6, and IL-21 
play a key role in autoimmunity whether as therapeutic targets or otherwise 
(Teichmann et al. 2012; Ray et al. 2012). 
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Systemic Lupus Erythematosus 
	  
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease 
leading to many abnormalities that involve the synthesis of autoantibodies that 
denote the breakdown of tolerance to self-antigens (Park et al 2002; Tsakos 
2001)  
 
Numerous environmental aspects, such as ultraviolet radiation, contribute to the 
pathogenesis of SLE (Yurasov et al. 2005).  SLE involves TNF-α, IL- 6, IL-10, 
CD4+ T cells and is distinguished in the oral cavity by the presentation of white 
and red plaque as well as recurrent aphthous stomatitis (Pijpe et al. 2009).  	  
Crohn’s Disease 
	  
Crohn’s disease is an inflammatory bowel disease that affects alimentary canal 
with a particular focus on the mouth. Characteristic granulomatous lesions as 
well as oral ulcerations are present (Rousseay et al. 2008).  
The cause of Crohn’s is multifactorial in addition to interaction between 
environmental risk factors and variations in the patient’s immune system onset 
the disease in a genetically prone host (Selmi 2013). 
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Multiple Sclerosis 
Multiple sclerosis (MS) is an inflammatory disease mainly affecting the central 
nervous system, leading to the imparity of the sensory and the neurocognitive 
function. MS occurs mainly in younger adults with a predisposed genetic trait, 
which most likely requires a triggering environmental offense. Damage of the 
target tissue and the inability to repair are characteristic features, which may 
have several dental implications in case of injury. Damage is followed by the 
activation of CD4+ T cells and their differentiation into a Th1 phenotype 
(Lucchinetti et al. 2000). 
Manifestation 
 
Recently, a study uncovered that exposure to TLR agonists and xenobiotics can 
result in synergistic effects and the release of IL- 6. This mechanism is not 
directly related to autoimmune disease per se but the liaison between 
unregulated TLR signaling and inflammation is evident and suggested research 
claims that it could lead to autoimmune endpoints (Selmi et al .2012).  
Environmental contaminants, UV light exposure and chemical contact influence 
the Th17 response leading to a possible development of autoimmune disease in 
susceptible individuals. This was seen after the evaluation of Th17 in multiple 
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sclerosis, rheumatoid arthritis, and Crohn’s disease patients, where the data is 
convincing that involvement of environmental toxins has a direct correlation to 
the exacerbation of autoimmune disease through Th17 cells (Selmi et al .2012). 
 
Table 1 illustrates the proposed environmental considerations and the assumed 
virus-induced type I diabetes, triggering of TLR pathways intensifies the disease. 
Another example is the stimulation of the type I interferon pathway in Sjögren’s 
syndrome, which triggers autoantigen presentation and autoantibody production. 
Functional changes in TLRs have also been correlated with Systemic Lupus 
Erythematosus. 
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Table 1. The major categories of putative environmental agents and 
possible mechanisms of autoimmune disease.  
Amended from Selmi et al. 2012 
 
 
 
Environmental factors that have been associated with autoimmune diseases 
Infectious agents (bacteria, viruses) 
Chemicals/xenobiotics 
Adjuvants 
Physical elements (ultraviolet radiation) 
 
 
Possible mechanisms 
Polyclonal B cell activation; 
Direct effect impairing the immune response (Th17 cells); 
Effects on innate immunity (TLR, adjuvants); 
Direct interaction with regulatory cells (T regulatory cells); 
Modification of self antigens (post-translational modifications); 
Alterations of DNA methylation (epigenetics) 
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Etiology, Prevalence, and Incidence of Autoimmune Disease 	  
The exact etiology of autoimmune diseases is not well defined, however it is 
generally accepted that ethnicity, geography, and demographic location play an 
important role for certain autoimmune diseases (Cooper et al. 2009; Walsh et al. 
2000). 
 
Some autoimmune diseases are more prevalent than others ranging from 5 to 
500 cases diagnosed per 100,000 individuals: For example, rheumatoid arthritis 
has an incidence rate of 20 per 100,000 people, while multiple sclerosis is a rarer 
condition with less than one diagnosis per year (Cooper et al. 2009). There is an 
estimate of combined incidence rate for autoimmune diseases of 90 per 100,000 
people and prevalence rate of around three percent; some diseases cannot be 
accurately accounted for and therefore these estimates are conservative ones 
(Cooper et al. 2009). These chronic diseases have a significant impact on the 
economic costs, the medical care needs and the patient’s quality of life (Løva¨s 
et al. 2002).  
 
Patterns with respect to disease incidence show that more than three fourth of 
Sjögren’s disease, Multiple Sclerosis (MS), and Systemic Lupus Erythematosus 
(SLE) patients are primarily female and are detected and diagnosed between 
childhood and mid-adulthood but can also be found to affect woman at later 
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stages of life (Mavragani et al. 2006; Pijpe et al. 2009).  
Noteworthy variances have been observed in the age distribution among 
autoimmune diseases. Autoimmune disease could occur at any age, however it 
is important to note that some diseases have peaks at different ages (Gottenberg 
et al. 2009; Mavragani et al. 2006; Pijpe et al. 2009).  
 
Juvenile RA and Type 1 diabetes occur between the ages of eight and ten while 
Myasthenia Gravis appears and Rheumatoid Arthritis occurs later in mid-adult 
years.   
 
Myasthenia Gravis, MS, and Grave’s disease tend to occur at average between 
thirty and fifty years of age. Older age between forty and seventy is seen at 
diagnosis of thyroiditis, Sjögren disease, RA, and Wegener granulomatosis 
(Gottenberg et al. 2009; Mavragani et al. 2006; Pijpe et al. 2009). 
 
In addition, patterns of differences of specific autoimmune diseases among 
countries or different ethnic groups are not consistent across autoimmune 
diseases. For example, northern Europe is where multiple sclerosis and Type 1 
diabetes are more frequently seen. Furthermore, an increased risk of SLE has 
been reported amongst Asian and Afro-Caribbean immigrants in the United 
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Kingdom as well as the black population in the US. On the other hand, blacks 
tend to have a lower rate of Type I diabetes and multiple sclerosis as compared 
to whites. Rates for rheumatoid arthritis are quite similar among whites, blacks 
and Hispanics (Cooper et al. 2009; Løva¨s et al. 2002; Walsh et al. 2000).  
 
 
Temporal changes in incidence have occurred between several autoimmune 
diseases. Autoimmune pattern incidences differ in type I diabetes that shows an 
increase in the last 10 to 50 years, and RA that seem to have declined, as seen 
in the studies in the Pima Indians (Cooper et al. 2009). 
 
Jacobson et al. (1997) completed a study collecting data on 19 of the 24 selected 
diseases; Table 2 (Amended from Cooper et al., 2002) summarizes this analysis 
with information including Addison’s disease, adult-onset Type 1 diabetes, 
rheumatoid arthritis, systemic sclerosis, Wegener granulomatosis, vasculitis, and 
Sjögren disease. The estimated incidence numbers range from 1 per 100,000 for 
chronic active hepatitis, scleroderma, primary biliary cirrhosis, and Myasthenia 
Gravis to 20 per 100,000 people for adult rheumatoid arthritis, and thyroiditis.  
The prevalence ranged from about 5 per 100,000 for chronic active hepatitis and 
Wegener granulomatosis to more than 500 per 100,000 for Grave’s disease, 
thyroiditis, and rheumatoid arthritis.  
 
More than three fourth of thyroiditis, Sjögren, scleroderma, and systemic lupus 
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erythematosus patients are female, however, in multiple sclerosis and 
rheumatoid arthritis the percent of female patients is around sixty.  In 
autoimmune diseases that begin in childhood, such as diabetes type 1, there is a 
relatively equal risk between females and males (Cooper et al., 2002).  
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Table 2. Autoimmune Disease Incidence And Prevalence  
 
 Incidence Per 100,000 
person years 
Prevalence 
Per 100,000   
Percent female 
(%) 
Addison’s disease 0.6 14.0 93 
Chronic active Hepatitis 0.7 0.4 88 
    
Glomerulonephritis    
Primary  3.6 40.0 32 
IgA 2.4 23.2 67 
    
Diabetes Type 1    
Age <20 12.2 192.0 48 
Age 20 and up 8.1 No Data 35 
    
Grave disease/ 
hyperthyroidism  
   
All ages 13.9 1151.5 88 
Ages 10-19 No Data 106.9 67 
    
Multiple Sclerosis 3.2 58.3 64 
Myasthenia Gravis  0.4 5.1 73 
    
Myocarditis 0.1 No Data 45 
All ages 4.1 No Data 44 
Ages <15 No Data 150.9 67 
Pernicious Anemia 1.8 5.1 67 
    
Rheumatoid Arthritis     
Juvenile (age <16) 17 148 68 
Adult  23.7 860.0 75 
Systemic Sclerosis 1.4 4.4 92 
Sjögren disease 3.9 14.4 94 
Systemic Lupus 
Erythematosus  
7.3 23.8 88 
    
Thyroiditis/ hypothyroidism    
Ages >19 21.8 791.7 95 
Ages 10-19 No Data 532.1 83 
Wegener granulomatosis 1.0 3.0 51 
Primary Systemic 
Vasculitis  
2.0 14.5 43 
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Specific Cell Involvement in Autoimmunity  
 
Maintaining immune homeostasis, tolerance and inhibition at the onset of 
autoimmune disease is the main function of suppressor T cells (Chen et al. 
2003b; Wahl et al. 2005). Regulatory T cells (Tregs) are immunoregulatory cells 
derived either from the thymus: CD4+ CD25+ FoxP3 also known as natural 
Tregs, or in the peripheral blood also known as induced Tregs (Anuradha et al. 
2013).  
 
Treg control both the innate and adaptive immune responses. When a pathogen 
invades the body, Toll-like receptors are expressed which in turn lead to the 
stimulation of dendritic cells. Dendritic cells produce IL- 6 and TGF-β that further 
influence the development of Treg, it basically functions as a cycle (Pasare et al. 
2003; Verhasselt et al. 2004). T regulatory cells develop after antigen and TGF-β 
stimulation; IL-10 secreting T regulatory type 1 cells (Tr1) are produced after 
TGF-β, IL- 27, and antigen exposure. T regulatory (Treg) cells have a 
characteristic expression of CD4, CD25 and forkhead box P3 that have a vital 
role in the maintenance of immune tolerance (Selmi et al. 2012).  
 
The main function of T reg cells is protecting the host from unbalanced T cell 
activation. Regulatory T cells CD4+CD25+ mediate inflammatory and immune 
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reactions and can suppress CD4+CD25– T cell responses to antigens with the 
help of TGF-β through an antigen-nonspecific mechanism (Chen et al. 2003b; 
Oida et al. 2003; Shevach et al. 2002). Experiments in mice have shown that a 
reduction in CD4+ CD25+ T cells by neonatal thymectomy results in 
spontaneous progression of organ specific autoimmune diseases particularly 
autoimmune gastritis, wasting, and thyroiditis. Adoptive transfer of Treg can 
reverse the progress of these autoimmune complications (Sakaguchi et al. 2001). 	  
T cell proliferation is inhibited in HIV-1 immunodeficiency and in lung cancer 
patients by regulatory cells due to the increased number of CD4+ CD25+. Thus, 
regulatory T cells have an essential role in the maintenance of tolerance through 
the suppression of the immune system (Wahl et al., 2005). 	  
 
T regulatory cells are a heterogeneous family of type 3 Th (Th3) cells, T 
regulatory 1 (Tr1) cells, and CD4+CD25+ T cells, "naturally-occurring" regulatory 
T cells. Type 1 regulatory T (Tr1) cells are a subset of T reg cells that play a vital 
role in the maintenance of tolerance. The main mechanism is by secretion of high 
levels of IL-10 but minimal amounts of IL-2, IL-4 and IL-17.  This aspect sets Tr1 
cells apart from Th2 and Th17 cells. Similar to other T cell subsets, Tr1 cells can 
express FoxP3 when activated (Gregori et al. 2012). Th3 cells mainly produce 
transforming growth factor beta (TGF-β) and therefore have a TGF-β -dependent 
regulatory mechanism. 
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By contrast, CD4+CD25+ T cells act via a contact-dependent mechanism that 
involves the activity of TGF-β and IL-2. These cells do not divide; instead they 
play a role in significantly increasing the numbers of CD4+CD25- cells that 
eventually become CD4+CD25+ cytokine-independent suppressor cells by 
mechanisms that require both IL-10 and TGF-β (Chen et al. 2003a). Another 
feature of CD4+CD25+ T cells is the expression of the products of FoxP3 (Zheng 
et al. 2004)  
 
There are two subsets of CD 4+ T helper cells, Th1 and Th2 (Cooney et al. 
2013). Type 1 T helper (Th1) and type 2 T helper (Th2) are two cell-mediated 
specific immune responses; one is for isotype switching in B cells and the other 
is for clonal expansion. These responses develop against infections sustained by 
viruses and intracellular bacteria (Romagnani 2000). The differentiation of these 
subsets is regulated by multiple cytokines; IL-12 and interferon (IFN) α produced 
by APCs, propagating cellular immunity which eventually leads to tissue damage. 
Cytokines such as IL-4 perpetuate stimulation of the humoral immune response 
(Sakaguchi et al. 2001). The probability of determining the incidence of Th1- or 
Th2-dominated responses in pathologic or under normal conditions is limited. T 
cells produce most cytokines in small amounts, which are either transmitted from 
cell to cell or released in the environment (Romagnani 2000). 
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B regulatory cells and Natural Killer (NK) cells have been shown to produce IL-
10, a cytokine that produces Tr1. IL-10 and TGF-β, which secrete Th3, are 
subdivisions of induced T regulatory cells (Osnes et al. 2013).  
 
In autoimmunity, T helper 17 (Th17) synthesis cells occurs via factors, cells, 
transcription factors and cytokines including regulatory B cells (Breg), Interleukin 
6 (IL-6), regulatory T cells (Treg), B cells, Interleukin 23 (IL-23), transforming 
growth factor beta (TGF-β), and forkhead box P3 (FoxP3) (Ian et al. 2006; Mays 
et al. 2012; Salinas et al. 2013).   
 
Th17 cells are characterized by the secretion of IL-17 and their activation is 
enhanced through TLR signaling (Anuradha et al. 2013; Bedoya et al. 2013). A 
few correlations to autoimmune disease include the experimental animal model 
of multiple sclerosis where TLR agonists increased disease incidence, as well as 
suggested evidence that Th17 cell activation association with exacerbation of 
multiple sclerosis (Miossec et al. 2009; Selmi et al. 2012). 
 
Th17 plays a very distinct role in certain autoimmune diseases with its function 
being a vital defense against bacterial and fungal infections (Atianand et al 2013; 
Cooney et al. 2013).  Th17 cells act against pathogens and participate in 
response to extracellular bacteria and fungi infections, meanwhile Treg suppress 
the immune response to normal microbial flora and antigens; however, 
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unregulated Th17 activity leads to chronic inflammatory diseases (Miossec et al. 
2009; Selmi et al. 2012). 
 
Mechanisms of Regulatory T cell Suppression and Autoimmunity 
 
Treg are immunosuppressive and anergic and therefore CD4+ CD25+ Treg 
suppress T cell proliferation and cytokine production when activated. TGF-β is a 
potent cytokine and growth factor, and blocking it with a soluble TGF-β receptor, 
with neutralizing antibodies or with recombinant peptides interrupts the capacity 
of TGF-β to intervene responder T cell proliferation (Sakaguchi 2000; Wahl et al. 
2005). This reiterates that TGF-β is used for suppression (Chen et al. 2003b; 
Nakamura et al. 2001). TGF-β receptor type II allows for membrane-bound TGF-
β to interact with the CD4+ CD25–responder cells and therefore providing the 
link via which TGF-β present on the Treg manages the suppression of responder 
cells (Chen et al. 2003b; Nakamura et al. 2001).  
 
In healthy individuals CD4+CD25+ Treg cells have shown to be increased 
compared to patients where CD4+IL-10 Tr1 cells are increased. CD4+CD25+ 
high Treg cells reduction is a key effect attributed to immunoregulatory disruption 
in individuals with MCTD (Gregory et al. 2012). Tr1 cells increase in order to 
restore equilibrium between type 1 and type 2 cytokines in MCTD (Osnes et al. 
2013).  
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The relationship between CD4+CD25+ Treg and Th1-dependent pathogenesis in 
Rheumatoid Arthritis has no significant difference in suppressive activity between 
CD4+CD25+ T cells from peripheral blood of RA patients and healthy individuals 
(Chattopodhyay et al 2013). CD4+CD25+ T cells from peripheral blood reported 
to have significantly lower suppressive activity than those in the synovial fluid of 
RA patients. However, ongoing inflammation in the joints suggests the complex 
mechanisms of RA pathogenesis (Chen et al. 2002; Nakamura et al. 2001).  
 
The most prevalent immunological abnormality that patients with human SLE 
manifest is the production of pathogenic autoantibodies.  Unrestrained T cell 
hyper-responsiveness leads to uncontrolled B lymphocyte activation and 
therefore more antibody production, this in turn results in the production of 
antidouble-stranded DNA and antinuclear antibodies in SLE patients (Pijpe et al. 
2009). Upregulation of proinflammatory cytokines IFN-γ, IL- 6, IL-10, and IL-12 
elevate Th1 and Th2 responses. The abnormalities in T and B lymphocytes are 
viewed as the consequence of defective TGF-β production (Mavragani et al. 
2006). The most prevalent immunological abnormality that patients with human 
SLE manifest is the production of pathogenic autoantibodies. Unrestrained T cell 
hyper-responsiveness leads to uncontrolled B lymphocyte activation and 
therefore more antibody production, this in turn results in the production of 
antidouble-stranded DNA and antinuclear antibodies in SLE patients (Nakamura 
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et al. 2001). Upregulation of proinflammatory cytokines IFN-γ, IL-6, IL-10, and 
IL12 elevate Th1 and Th2 responses. The abnormalities in T and B lymphocytes 
are somewhat the consequence of defective TGF-β production (Anuradha et al. 
2013).  
 
Studies indicate that CD4+CD25+ T cells decrease significantly in number and 
function in patients with active SLE as opposed to patients with an inactive 
stages subjects and normal individuals (Crispin et al. 2003; Valencia et al. 2003). 
Having said this, an association between inactive SLE and the levels of 
CD4+CD25+ Treg is needed to define the exact role of decreased CD4+CD25+ 
Treg levels in the pathogenesis of the disease (Liu et al. 2004; Wahl et al. 2005). 
 
Consequently, any alteration in the population of these key cells and cytokines 
will lead to the triggering or onset of an autoimmune disease such as SLE, RA or 
Mixed Connective Tissue Disease (MCTD), as well as immunodeficiency or 
autoimmunity in general (Osnes et al. 2013). 
 
Patients with autoimmune diseases (AUIDs) such as SLE, RA or even mixed 
connective tissue disease (MCTD) have been reported to have a diminished 
number or activity of NK cells and Th17 cytokines (Chen et al. 2003b; Nakamura 
et al. 2001).  In MCTD, CD4+ and CD8+ T cells make more IL-10, an effort by 
immune system, to down regulate the inflammatory reaction (Nakamura et al. 
	  23	  	  
2001; Osnes et al. 2013). Whether the humoral or cellular immunity is activated 
in a AUIDs patient, understanding the mechanism will aid in identifying the 
immunological pathways that lead to advancement of disease, therefore 
improvement of therapeutic outcomes (Osnes et al. 2013). 
 
Pathogenic Infections and Autoimmune diseases  	  
One of the unresolved queries in immunology is how pathogenic infections 
contribute to the etiology of autoimmune diseases. The concept of antigen 
mimicry is considered. Antigen mimicry is defined as sequences in microbial 
proteins resembling that of the host’s own protein molecules (Leo’na et al. 2003).  
In contrast, some studies propose a contrary association between the 
occurrences of autoimmunity and infections, as in; infection seems to prevent the 
onset of autoimmunity. This theory is called “the hygiene hypothesis”, which 
states that the increased occurrence of autoimmune disease is correlated to the 
diminished incidence of infection (Okada et al. 2010). The basis of this theory 
states that if low-grade infections are repeated, immune system will respond 
without aggression. A theoretical model of tolerance driven by regulatory T cells 
helps clarify both ideas. To determine whether infections may be causing or 
preventing autoimmune diseases, mechanisms of natural tolerance to host-
antigens must be observed. Regulatory T cells, CD4+ CD25+, naturally 
synthesized in the thymus, are dependent on major histocompatibility complex 
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(MHC)-Class II expression. Regulatory T cells, overpower the activity of other 
pathogenic auto-reactive T cells (Chattopodhyay et al. 2013; Leo’na et al., 2003).  
The results have shown that an inverse correlation exists between the 
occurrence of autoimmunity and incidence of infection. This could be viewed 
based on regulatory T cell, and also accounting for the role of antigen mimicry in 
the etiology of some autoimmune disorders (Leo’na et al. 2003).   
 
APCs displaying MHC-self-peptide complexes, proinflammatory autoreactive T 
cells that can possibly incite autoimmunity, and regulatory autoreactive T cells, 
which suppress proinflammatory T cells were studied. Fast surge in antigen 
presenting cells reduce interaction between proinflammatory and regulatory 
autoreactive T cells leading to the onset of autoimmunity (Jonuleit et al. 2001; 
Leo’na et al. 2003). Regulatory autoreactive T cells inhibit the profileration 
proinflammatory autoreative T cells at the APC surface (Leo’na et al. 2003). Slow 
APC increase allows for adaptation of the regulatory cell population size, 
therefore reinforcing tolerance (Figure 1). Therefore the concepts of immunity 
and tolerance are explained as the competitive seclusion of regulatory 
autoreactive T cells as proinflammatory autoreactive T cells increase in 
population as well as the concomitance of both T cells types at balance (Leo’na 
et al. 2003). 
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Infection and Response: APC proliferation 
When an infection occurs in the body, at first the innate immune system is 
triggered to clear the microorganism, which provokes a rapid burst in the 
recruitment of antigen presenting cells that rush to the site of the infection for 
proper control. Differentiation and proliferation of antigen presenting precursors 
ensues which will then lead to the processing and presentation of foreign 
antigens (Leo’na et al. 2003). If the proliferation of APCs is rapid, it causes an 
increase in pro-inflammatory autoreactive T cells and therefore a collapse of 
tolerance. On the other hand, if there is proliferation of APCs but it occurs rather 
slowly, there will still be an increase in pro-inflammatory autoreactive T cells, 
which is controlled by the proliferation of regulatory T cells, however no break in 
tolerance occurs (Leo’na et al. 2003). 
 
Significant improvement in self-antigen presentation would either provoke or 
prevent autoimmunity when accompanied by rapid or slow kinetics, respectively.  
Inoculation of Non-Obese Diabetic (NOD) mice with different doses of antigen 
presenting cells from the spleen of non-treated NOD mice and checking the 
incidence of animals developing diabetes indicated that treatments including a 
significant inoculum with those APCs would quicken the early onset of diabetes 
(Leo’na et al. 2003). 
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According to recent reports by Leo’na et al., when the innate immune system is 
activated, dendritic cells produce IL 2, a cytokine that serves as a resource for 
regulatory T cells. If there happens to be excess in IL 2 synthesis in pathological 
situations with infectious basis, the balance between regulatory and 
proinflammatory cells would become subverted, resulting in generalized 
immunodepression (Leo’na et al. 2003; Oida et al. 2003). 
 
T cell responses to foreign antigens are vital for the protection of organism 
against pathogenic agents, however T cell response to self-antigens is 
detrimental. The lack of regulation of T cell activation and development results in 
autoimmune diseases, which entails inflammation and the destruction of tissue 
(Sakaguchi 2000; Jonuleit et al. 2001).   
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Dental Management of Autoimmune Diseases 	  	  
To date, no clear correlation has been demonstrated between AUIDs and oral 
manifestation. It has been suggested that the increase in bacteria on the tooth 
surface may serve to trigger the immune system mobilizing T cells, B cells, mast 
cells, NK cells and macrophages as a defense mechanism of against these 
invading bacteria perceived as foreign bodies (Manakil 2012). 
 
Conventionally, most autoimmune diseases are treated through medical 
specialties depending on the type of organ involved. Due to this fact, there are 
many missed opportunities to study autoimmune diseases as an entity (Cooper 
et al. 2009). To understand the etiology of autoimmune diseases, further studies 
of the relationships among them is necessary.  
 
The general principles for treatment of autoimmune diseases with oral 
manifestations include oral hygiene reinforcement using antiseptics, antibiotics, 
and corticosteroids.  Specifically, corticosteroids are used to manage the oral 
ulcers in Behcet’s syndrome (Gottenberg et al. 2009).  Dentists address the 
difficulties that RA patients face due to their limited manual dexterities by 
performing regular oral hygiene checkups, more preventative oral hygiene 
maintenance as well as diagnosis and treatment of periodontal disease as early 
as possible.  Dental care with fluoride and routine checkups, azole, antifungal 
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treatment, is utilized for patients with Sjögren’s syndrome and mouthwashes, 
special toothpastes and mouth rinses are used to alleviate Xerostomia (Mays et 
al. 2012). However, care must be taken in utilizing azole antifungal agents 
because many chemicals in medications interact with this type of mouth rinse. 
For treatment of plaque and stomatitis in SLE, clobetasol and tacrolimus 
ointment are used as well as systemic administration of immunodeficiency drugs 
such as Rituximab, a B-cell inhibitor (Mendes et al. 2009).   
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DISCUSSION 	  
The presence of auto-reactive B and T lymphocytes in the periphery characterize 
the physiological process in autoimmunity and it can be concluded that 
environmental factors, physical elements and chemical adjuvant trigger the 
transformation from autoimmunity to autoimmune disease.  
 
When discussing the effects of innate immunity and their role in linking 
environmental factors and autoimmune disease it is important to mention the two 
major pathways highlighted, TLR and adjuvants. The activation of the innate 
immune system through toll-like receptors and their interaction between 
xenobiotics is predisposed by the interaction of environmental factors and 
therefore has a direct link on autoimmunity development (Anuradha et al. 2013; 
Selmi et al. 2012) Moreover, it is clear that adjuvants stimulate the innate and 
adaptive immune system and therefore prompt the release of cytokines and 
chemokines, as well as induce non-antigen-specific signals that identify adaptive 
responses triggering for autoimmune pathology. However it is not clear whether 
deregulation of TLR is a prominent step in triggering autoimmunity, or whether 
genetic predisposition has a more ponderous role in relation to these factors.  
 
Given the previous discussion on environmental factors influencing autoimmune 
development, it can be postulated that this influence occurs via production or 
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activation of Treg cells. Treg cells (suppressor T cells) are concluded to be 
responsible for active immunosuppression of responses to foreign and self-
antigens leading to autoimmune disease. Therefore, stating that down-regulation 
of Treg subsets or their alteration by any environmental or chemical factor is a 
direct correlation with the onset of autoimmune disease is accurate (Chen et al. 
2002; Nakamura et al. 2001).  
 
The nature of interface between T cells and antigen presenting cells (APCs) 
predicts production of efficient Th1, Th2, Th17 and Treg cells. Therefore, 
environmental queues also have a significant effect on APC and vis a vis an 
effect on Treg cells (Chen et al. 2002). 
 
The phenomenon of autoimmunity includes the loss of B cell anergy, the failure 
of T regulatory cells, and the synthesis of auto-reactive T cells and 
autoantibodies. These mechanisms eventually lead to tissue injury that begins 
from the synthesis of pro-inflammatory cytokines and continues toward 
chemotaxis of immune cells to the target sites.  
 
Figure 2. summary description of  the mechanisms of immunity and therefore 
serves as a step forward in understading the mechanisms and pathology behind 
autoimmunity.  
 
	  32	  	  
 
 
	  33	  	  
 
 
Figure 2. Illustration of the Immune Response Mechanism. 
 
Reproduced with permission from a book chapter "Janket SJ, Kanasi E, Baird AE. Oral 
Infection and autoimmunity. In: Shoenfeld Y, Agmon-Levin N, Rose NR, eds. Infection 
and autoimmunity. Vol XX. 2 ed. Waltham, MA Elsevier BV; 2014." 
 
(A) , T cells are part of both innate and adaptive immunity, on the contrary to 
B cells, which only exist when the adaptive immune response comes into play. 
Natural Killer cells also play a significant role in the rapid innate immune 
response (Osnes et al., 2013). Natural T regulatory cells include cells that 
express CD4+ CD25+ and forkhead box P3 (Foxp3) stimulate the formation of 
Th1 and Th2 helper cells, where cellular and humoral response is initiated 
respectively.  Antigen Presenting cells also play a role in stimulating Th1 and th2 
cells by secreting cytokines such as IL-12, Interferon-Gamma, and IL-14. Th1 
response leads to Interferon-r/anti-infection cytokine, phagocytosis, Th2 
response doesn’t activate anti-infective action macrophages, however this 
pathway leads to antibody production via B cells.  
 
(B) , A Naïve T cell in the presence of TGF-β and IL-6 leads to the formation 
of Th17. In the presence of TGF-β only, a naïve T cell will progress to T  
regulatory cell leading to lower inflammation and a reduced immune response.  
 
(C) , B cell activation eventually leads to ectopic germinal center activation, if 
TGF-β and IL-10 are involved, B regulatory cells will play a role in autoimmune 
suppression. Otherwise, B cell activation will move forward to somatic hyper-
mutation and immune pathogenesis.  
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To further elaborate on the process that occurs it must be mentioned that early 
expression of IL-4 during an immune response is very important in the 
determination of Th2 development. When a weak T-cell receptor (TCR) signal is 
received, naïve CD 4 cells seem to be receptive to CD28-dependent IL-4 
production. When IL-4 levels reach a certain threshold, differentiation of Th cells 
into T helper 2 cells occurs. Moreover, Th17 is a vital part and plays a rather 
significant role in autoimmunity through its pro-inflammatory T helper cytokine 
production of IL-17. Th17 is very crucial since the defense against fungal and 
bacterial infections mainly relies on this cell population, therefore, IL-17 can be 
either protective or damaging. The study of Th17 and T regulatory cells as well 
as IL-17 has been found to act on both neutrophil chemotaxis and endothelial 
activation therefore associating two major chronic inflammation mechanisms 
(Ray et al. 2012). A few studies mentioned earlier have supported the target of 
Th17 in the treatment of autoimmunity however the mechanisms of periodontal 
infections may complicate this process. This is complicated due to evidence of an 
IL-2 dependent mechanism, the expression of dopamine receptor (D5) by 
dendritic cells, and the altered expression of TGF-β (Selmi et al. 2012). 
 
In discussing T regulatory cells, it is important to re-emphasize that they are 
crucial to prevention of autoimmunity; they have many functional features and 
one in particular is to preserve self-antigen tolerance. However, this can cause 
fulminant infection when viral infections invade the central nervous system. Th1 
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cells producing Interferon, tumor necrosis factor, and IL- 2 lead to evoke cell-
mediate immunity.  Th2 cells produce IL-4, IL-5, IL-6, IL-9, IL-10, and IL-13. 
These cells induce strong antibody responses; however, also play a role in 
inhibiting phagocytic cell functions.  
 
Autoimmune responses such as Crohn’s disease are Th1-dominated responses. 
On the other hand, Th2 allergen-specific responses are responsible for atopic 
disorders in genetically predisposed individuals (Romagnani 2000).Therefore in 
order to distinguish whether a Th1 or a Th2 response is involved, both 
environmental and genetic factors need to be evaluated. 
 
T regulatory cells are the main driving force for autoimmune control and therefore 
the pathogenesis of inflammation, infections and autoimmunity is constrained by 
cluster of differentiation CD4+ CD25+ regulatory T cells that facilitate 
suppression of the immune system. As we stated earlier, CD4+ CD25+ act via a 
contact-dependent, antigen-specific means with the aid of TGF-β, which holds a 
dual function in mediating suppression between CD4+CD25– as well as the 
conversion of CD4+ CD25- into the regulatory phenotype ((Chen et al. 2003b; 
Leo’na et al. 2003).    
 
By the immune system responding to pathogens, a risk of autoimmunity is a 
direct price to pay. Epidemiological and experimental models till today have failed 
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to pinpoint the etiology of autoimmune diseases. The only hypothesis viable 
today, concluded by a genome-wide association study is that autoimmunity 
generates from a combination of genetic and environmental factors. 
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CONCLUSION 
 
 
The failure of self-recognition that leads to immune responses triggered against 
an organism’s own cells is described as autoimmunity. Autoimmunity progresses 
from a benign to a pathogenic response due to both environmental influences 
and genetic predispositions. As was seen in Table 1, in the context of 
autoimmunity, adjuvants retain the capacity to stimulate the release of 
proinflammatory chemokines and cytokines as well as induce non-antigen-
specific signals that identify adaptive responses triggering for autoimmune 
pathology. Further inquiries should also focus on genetic predisposition and its 
relation to these factors.  
 
Autoimmune diseases are among the leading causes of death in young and 
middle-aged women. With the exception of Type I diabetes, autoimmune disease 
is seen to affect predominantly women. Autoimmune pattern incidences differ, 
where some in the example of type I diabetes tend to have increased in the last 
half century, while others like RA seem to have declined over the same period.  
 
In terms of mechanisms of autoimmunity, it can be concluded from this   review 
that CD4+ CD25+ forkhead box P3 (Foxp3) regulatory T cells can suppress 
responder T cell proliferation and cytokines and stimulate the formation of Th1 
and Th2 helper cells, where cellular and humoral response is initiated 
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respectively. Th1 response leads to phagocytosis, while the Th2 response leads 
to antibody production via B cells.  
 
 A characteristic feature of CD4+CD25+ Tregs is their ability to suppress a range 
of different responses mediated by both innate and adaptive immune systems. 
Therefore the reduction of CD4+CD25+ T cells in an organism affects the 
development of spontaneous autoimmune disorders, emphasizing the 
importance of Treg and their protective role against autoimmunity. These natural 
Tregs act mainly by Tcell to APC contact in a cytokine-independent manner 
where mechanisms of suppression are facilitated by the production of inhibitory 
cytokines, such as IL 10 and TGF-β.  Mechanisms of regulation of these T regs 
are also possible in order to diminish, and not just enhance, their numbers and 
activity to reverse immunodeficiency. 
 
B regulatory cells play a role in autoimmune suppression and their activation with 
the involvement of IL 10 and TGF-­‐β leads to germinal center activation  
B cell activation eventually leads to ectopic germinal center activation, if TGF 
beta and IL10 are involved (Osnes et al. 2013).  B cell development checkpoints 
guarantee that auto-reactive B cells are discarded. Correspondingly, autoimmune 
disease is directly related to tolerance checkpoint dysfunction. We can also 
conclude that Th17 is another important immune checkpoint where their 
unregulated activity can result in immunopathology. Alterations in the Th17 
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response will hopefully be a significant therapeutic focus in autoimmune disease 
patients.  
 
The presence of oral ulcerations is almost always an autoimmune indication and 
is similar in the many autoimmune disease presented, the pathogenesis of these 
ulcerations, however, may differ. No clear association has been proven between 
AUIDs and oral manifestation. From the data suggest by Manakil 2012 it can be 
concluded the increased bacterial layer on tooth surfaces may have a role in the 
onset an immune response.  
 
As Mays et al. reported in 2012 our studying corroborates their findings that early 
detection by dental professionals will allow both the healthcare provider and the 
patient to communicate an approach to moderate, alleviate or prevent disease 
development. Early detection and management of autoimmune diseases is not 
easy, and therefore dentists play a significant role to manage the multidisciplinary 
medical complexity such as autoimmune diseases. Managing inflammatory 
issues is not unique to each disease and can be applied with the use of steroids 
or antimicrobial treatment.  Persistent and developed examination of autoimmune 
diseases will improve our understanding of disease burden and progressive 
trends.  
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In conclusion, a common effort in research is needed to determine whether 
common immunological pathways might be significant in several conditions. Next 
generation sequencing and pathway analyses must be envisioned in terms of 
autoimmunity in general and might help provide mutual aims for new therapies. 
Studying monozygotic twins, with one being the control and the other as the 
patient, is optimal idea for determining the significance of environmental, genetic, 
and epigenetic aspects in the susceptibility to autoimmune diseases.   
 
	  41	  	  
LIST OF JOURNAL ABBREVIATIONS 	  	  
Am J Public Health    American Journal of Public Health  
Ann Neurol     Annals of Neurology 
Annu Rev Immunol    Annual Review of Immunology   
Arthritis Res Ther     Arthritis Research and Therapy  
Arthritis Rheum    Arthritis and Rheumatology  
Biomed Res Int     BioMed Research International  
Cell Mol Immunol    Cellular and Molecular Immunology 
Clin Immunol    Clinical Immunology  
Crit Rev Immunol    Critical Reviews in Immunology  
Curr Dir Autoimmun   Current Directions in Autoimmunity  
Eur J Immunol    European Journal of Immunology  
Exp Gerontol    Experimental Geronotology  
FEBS Lett    FEBS Letters  
Immunol Rev     Immunological Reviews 
Immunol Today    Immunology Today  
J Autoimmun              Journal of Autoimmunity 
J Clin Endocrinol    Journal of Clinical Endocrinology  
J Clin Immunol   Journal of Clinical Immunology  
J Evid Based Dent Pract     Journal of Evidence-Based Dental Practice 
J Exp Med     Journal of Experimental Medicine 
	  42	  	  
J Immunol    Journal of Immunology 
J Mol Immunol     Journal of Molecular Immunology  
J Transl Med    Journal of Translational Medicine 
J Vis Exp     Journal of Visualized Experiments 
Nat Clin Pract Rheumatol  Nature Clinical Practice Rheumatology  
Nat Rev Immunol    Nature Reviews Immunology  
N Engl J Med    New England Journal of Medicine 
Pediatr Allergy Immunol    Pediatric Allergy and Immunology  
Semin Immunol    Seminars in Immunology 
	  43	  	  
REFERENCES 
 
   
Anuradha R, George PJ, Hanna LE, Chandrasekaran V, Kumaran P, Nutman 
TB, Babu  S (2013). IL-4-, TGF-β-, and IL-1-dependent expansion of parasite 
antigen-specific Th9 cells is associated with clinical pathology in human 
lymphatic filariasis. J Immunol. ;191(5):2466-73.  
 
Atianand MK, Fitzgerald KA (2013). Molecular basis of DNA recognition in the 
immune system. J Immunol ;190(5):1911-8.  
 
Atzeni F, Talotta R, Salaffi F et al (2012) Immunogenicity and autoimmunity 
during anti-TNF therapy. Autoimmunity reviews 30: 279–300. 
 
Bedoya SK, Wilson TD, Collins EL, Lau K, Larkin J 3rd (2013). Isolation and th17 
differentiation of naïve CD4 T lymphocytes. J Vis Exp.;(79):e50765. 
 
Cervantes-Barragan  L, Firner S, Bechmann I et al (2012). RegulatoryT cells 
selectively preserve immune privilege of self-antigens during viral central nervous 
system infection. J Immunol 188:3678. 
 
Chattopadhyay G, Shevach EM (2013). Antigen-Specific Induced T Regulatory 
Cells Impair Dendritic Cell Function via an IL-10/MARCH1-Dependent 
Mechanism. J Immunol. 
Chen, W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM 
(2003a). Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ 
regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp 
Med. 
 
Chen W, Wahl SM (2002). TGF-beta: receptors, signaling pathways and 
autoimmunity. Curr Dir Autoimmun 5:62-91. 
 
Chen W, Wahl SM (2003b).TGF-β: the missing link in CD4+CD25+ regulatory T 
cell-mediated immunosuppression.Cytokine Growth Factor Rev, 14:85-89. 
Chong WP, Horai R, Mattapallil MJ, Silver PB, Chen J, Zhou R, Sergeev Y, 
Villasmil R, Chan CC, Caspi RR (2013). IL-27p28 inhibits central nervous system 
autoimmunity by concurrently antagonizing Th1 and Th17 responses. J 
Autoimmun.   
 
	  44	  	  
Cooney LA, Fox DA (2013). Regulation of Th17 maturation by interleukin 4. Crit 
Rev Immunol ;33(5):379-87.  
 
Cooper GS, Bynum ML, Somers EC (2009). Recent insights in the epidemiology 
of autoimmune diseases: improved prevalence estimates and understanding of 
clustering of diseases. J Autoimmun 33(3-4):197-207. 
 
Cooper GS, Stroehla BC (2003). The epidemiology of autoimmune diseases. 
Autoimmunity reviews 2(3):119-125. 
 
Crispin JC, Martinez A, Alcocer-Varela J (2003). Quantification of regulatory T 
cells in patients with systemic lupus erythematosus. J Autoimmun, 21:273-276. 
 
Davidson MG, Alonso MN, Yuan R, Axtell RC, Kenkel JA, Suhoski MM, 
González JC, Steinman L, Engleman EG (2013). Th17 cells induce Th1-
polarizing monocyte-derived dendritic cells. J Immunol.;191(3):1175-87.  
 
De Paus RA, Geilenkirchen MA, van Riet S, van Dissel JT, van de Vosse E. 
Differential expression and function of human IL-12Rβ2 polymorphic variants. J 
Mol Immunol. (4):380-9. doi: 10.1016/j.molimm.2013.07.002. 
 
Edwards JCW, Szczepański L, Szechiński J, Filipowicz-Sosnowska A, Emery P, 
Close DR, Stevens RM, and Shaw T (2004). Efficacy of B-Cell–Targeted 
Therapy with Rituximab in Patients with Rheumatoid Arthritis. 
N Engl J; 350:2572-2581DOI: 10.1056/NEJMoa032534 
 
Fisher Y, Strominger I, Biton S, Nemirovsky A, Baron R, Monsonego A (2013). 
Th1 Polarization of T Cells Injected into the Cerebrospinal Fluid Induces Brain 
Immunosurveillance. J Immunol.  
 
Gottenberg JE, Miceli-Richard C, Ducot B, Goupille P, Combe B, Mariette X 
(2009). Markers of B-lymphocyte activation are elevated in patients with early 
rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort. 
Arthritis Res Ther 11(4):R114. 
 
Gregori,S, Bacchetta R, Battaglia M,  Roncarolo MG (2012). Type 1 regulatory T 
(Tr1) cells: from the bench to the bedside. J Transl Med10(Suppl3):I7. 
 
Jacobson DL, Gange SJ, Rose NR, Graham NMH (1997). Epidemiology and 
Estimated Population Burden of Selected Autoimmune Diseases in the United 
States. Clinical immunology and immunopathology . Vol. 84, No. 3, pp. 223–243, 
Article No. II97441. 
 
Janket SJ, Kanasi E, Baird AE (2014). Oral Infection and autoimmunity. In: 
	  45	  	  
Shoenfeld Y, Agmon-Levin N, Rose NR, eds. Infection and autoimmunity. Vol 
XX. 2 ed.  
 
Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH (2001). 
Identification and functional characterization of human CD4+CD25+ T cells with 
regulatory properties isolated from peripheral blood. J Exp Med 193:1285-1294. 
 Kleinewietfeld M, Hafler DA (2013). The plasticity of human Treg and Th17 cells 
and its role in autoimmunity. Semin Immunol.  
 
Kluger MA, Ostmann A, Luig M, Meyer MC, Goerke B, Paust HJ, Meyer-
Schwesinger  C, Stahl RA, Panzer U, Tiegs G, Steinmetz OM (2013). B-cell-
derived IL-10 does not vitally contribute to the clinical course of 
glomerulonephritis. Eur J Immunol. doi: 10.1002.  
 
León K, Faro J, Lage A, Carneiro J (2004). Inverse correlation between the 
incidences of autoimmune disease and infection predicted by a model of T cell 
mediated tolerance. J of Autoimmu 22(1):31-42. 
 
Liang D, Zuo A, Shao H, Born WK, O'Brien RL, Kaplan HJ, Sun D (2013). IL-23 
receptor  expression on γδ T cells correlates with their enhancing or suppressive 
effects on autoreactive T cells in experimental autoimmune uveitis. J Immunol. 
1;191(3):1118-25. doi: 10.4049.  
 
Lim MA, Lee J, Park JS, Jhun JY, Moon YM, Cho ML, Kim HY (2013). Increased 
Th17 differentiation in aged mice is significantly associated with high IL-1β level 
and low IL-2 expression. Exp Gerontol.  
 
Liu MF, Wang CR, Fung LL, Wu CR (2004). Decreased CD4+CD25+ T cells in 
peripheral blood of patients with systemic lupus erythematosus. Scand J 
Immunol, 59:198-202. 
 
Lleo A, Pietro Invernizzi P, Gao B,  Podda M,  Gershwina EM (2010). Definition 
of human autoimmunity — autoantibodies versus autoimmune disease. 
Autoimmunity Reviews 9 (2010) A259–A266.  
 
Løva¨s K, Husebye ES (2002). High prevalence and increasing 
incidence of Addison’s disease in western Norway. J Clin Endocrinol (Oxf) 
56:787 –91. 
 
Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H 
(2000). Heterogeneity of multiple sclerosis lesions: implications for the 
pathogenesis of demyelination. Ann. Neurol. 47:707–17.  
 
 
	  46	  	  
Maseda D, Smith SH, DiLillo DJ et al (2012). Regulatory B10 cells 
differentiate into antibody-secreting cells after transient IL-10 production 
in vivo. J Immunol 188:1036–1048. 
 
Mavragani CP, Moutsopoulos NM, Moutsopoulos HM (2006). The management 
of Sjögren’s syndrome. Nat Clin Pract Rheumatol 2(5):252-61. 
 
Mays JW, Sarmadi M, Moutsopoulos NM (2012). Oral manifestations of systemic 
autoimmune and inflammatory diseases: diagnosis and clinical management.  J 
Evid Based Dent Pract. (3 Suppl):265-82.  
 
Mendes D, Correia M, Barbedo M, Vaio T, Mota M, Gonçalves O, Valente J 
(2009). 
Behçet's disease--a contemporary review. J Autoimmun 32(3-4):178-88. 
 
Miossec P, Korn T, Kuchroo VK (2009). Interleukin-17 and type 17 helper T 
cells. N Engl J Med 361(9):888-98. 
 
Mosmann TR, Coffman RL (1989). TH1 and TH2 cells: different patterns of 
lymphokine secretion lead to different functional properties. Annu Rev Immunol 
7: 145-73. 
 
Mosmann TR, Sad S. (1996). The expanding universe of T-cell subsets: Th1, 
Th2 and more. Immunol Today 17:138-46. 
 
Nakamura K, Kitani A, Strober W (2001). Cell contact-dependent 
immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell 
surface-bound transforming growth factor beta. J Exp Med 194:629-644. 
 
Oida T, Zhang X, Goto M, Hachimura S, Totsuka M, Kaminogawa S, Weiner HL 
(2003). CD4+CD25– T cells that express latency-associated peptide on the 
surface suppress CD4+CD45RBhighinduced colitis by a TGF-beta-dependent 
mechanism. J Immunol. 170:2516-2522. 
 
Okada H, Kuhn C, Feillet H, and Bach JF (2010). The ‘hygiene hypothesis’ for 
autoimmune and allergic diseases: an update. Clinical & Experimental 
Immunology, 160: 1–9. doi: 10.1111/j.1365-2249.2010.04139.x 
 
Osnes LT, Nakken B, Bodolay E, Szodoray P (2013). Assessment of intracellular 
cytokines and regulatory cells in patients with autoimmune diseases and primary 
immunodeficiencies - novel tool for diagnostics and patient follow-up. 
Autoimmunity reviews 12(10):967-971. 
 
	  47	  	  
Parks CG, Cooper GS, Nylander-Frenc LA, Sanderson WT, Dement JM, Cohen 
PL, Dooley MA, Treadwell EG, St Clair EW, Gilkeson GS, Hoppin JA, and Savitz 
DA (2002). Occupational exposure to crystalline silica and risk of systemic lupus 
erythematosus: a population-based, case-control study in the southeastern 
United States. Arthritis Rheum. 46(7), 1840–1850. 
Pasare C, Medzhitov R: Toll pathway-dependent blockade of CD4+CD25+ T cell-
mediated suppression by dendritic cells (2003). Science, 299:1033-1036. 
 
Pijpe J, Meijer JM, Bootsma H, van der Wal JE, Spijkervet FK, Kallenberg CG 
(2009). Clinical and histologic evidence of salivary gland restoration supports the 
efficacy of rituximab treatment in Sjögren's syndrome. Arthritis Rheum 
60(11):3251-6. 
 
Ray A, Basu S, Williams CB, Salzman NH, Dittel BN (2012). A 
novel IL-10-independent regulatory role for B cells in suppressing 
autoimmunity by maintenance of regulatory T cells via GITR ligand. 
J Immunol 188:3188–3198.  
 
Romagnani S (2000). T-cell subsets (Th1 versus Th2).Department of Internal 
Medicine, Section of Immunoallergology and Respiratory Diseases.  
Rousseau MC, Parent ME, St-Pierre Y (2008). Potential health effects from non-
specific stimulation of the immune function in early age: the example of BCG 
vaccination. Pediatr Allergy Immunol,  pp. 438–448. 
Sakaguchi S (2000). Regulatory T cells: key controllers of immunologic self-
tolerance. 101:455-458. 
 
Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, 
Kuniyasu Y, Nomura T, Toda M, Takahashi T (2001). Immunologic tolerance 
maintained by CD25+ CD4+ regulatory T cells: their common role in controlling 
autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 
182:18-32. 
 
Salinas GF, Braza F, Brouard S, Tak PP, Baeten D (2013). The role of B 
lymphocytes in the progression from autoimmunity to autoimmune disease. Clin 
Immunol 146(1):34-­‐45. 
 
Selmi C (2013). Autoimmunity in 2012. Clinical reviews in allergy & immunology 
45(2):290-301. 
 
Selmi C, Leung PS, Sherr DH, Diaz M, Nyland JF, Monestier M et al. (2012). 
Mechanisms of environmental influence on human autoimmunity: a National 
Institute of Environmental Health Sciences expert panel workshop. J Autoimmun 
	  48	  	  
39(4):272-284. 
 
Shah A (2012). The pathologic and clinical intersection of atopic and autoimmune 
disease. Current allergy and asthma reports 12(6):520-529. 
 
Shevach EM (2002). CD4+ CD25+ suppressor T cells: more questions 
than answers. Nat Rev Immunol 2:389-400. 
 
Sledzińska A, Hemmers S, Mair F, Gorka O, Ruland J, Fairbairn L, Nissler A, 
Müller W, Waisman A, Becher B, Buch T (2013). TGF-β signalling is required for 
CD4⁺ T cell homeostasis but dispensable for regulatory T cell function. PLoS Biol 
:e1001674.  
 
Talaei N, Cheung YH, Landolt-Marticorena C, Noamani B, Li T, Wither JE (2013). 
T cell and dendritic cell abnormalities synergize to expand pro-inflammatory T 
cell subsets leading to fatal autoimmunity in B6.NZBc1 lupus-prone mice. PLoS 
One. 20;8(9). 
 
Tapinos NI, Polihronis M,Moutsopoulos HM (1999). Lymphoma development 
in Sjögren's syndrome: Novel p53 mutations. Arthritis & Rheumatism Volume 
42, Issue 7, pages 1466–1472.  
 
Teichmann LL, Kashgarian M, Weaver CT, Roers A, Muller W, 
Shlomchik MJ (2012). B cell-derived IL-10 does not regulate spontaneous 
systemic autoimmunity in MRL.Fas(lpr) mice. J Immunol 188:678–685. 
 
Tsokos GC (2001). Systemic lupus erythematosus. A disease with a complex 
pathogenesis. Lancet 358 (Suppl), S65. 
 
Vadasz Z, Haj T, Kessel A, Toubi E (2013). B-regulatory cells in autoimmunity 
and immune mediated inflammation. FEBS Lett. 27;587(13):2074-8.  
 
Valencia X, Olson D, He LS, Illei G, Lipsky P (2004). CD4+CD25+ T regulatory 
cells in autoimmune diseases. Arthritis Rheum, 48 Suppl. S:411. 
 
Verhasselt V, Vosters O, Beuneu C, Nicaise C, Stordeur P, Goldman M (2004). 
Induction of FOXP3-expressing regulatory CD4pos T cells by human mature 
autologous dendritic cells. Eur J Immunol, 34:762-772. 
 
Wahl SM, Chen W (2005). Transforming growth factor-beta-induced regulatory T 
cells referee inflammatory and autoimmune diseases. Arthritis Res Ther 7(2):62-
68. 
 
Walsh SJ, Rau LM (2000). Autoimmune diseases: a leading cause of death 
	  49	  	  
among young and middle-aged women in the United States. Am J Public Health 
90:1463.  
 
Wang X, Feng X, Wang J, Shao N, Ji C, Ma D, Henter JI, Fadeel B, Zheng C 
(2013). Bortezomib and IL-12 produce synergetic anti-multiple myeloma effects 
with reduced toxicity to natural killer cells. Anticancer Drugs.  
 
Yang M, Rui K, Wang S, Lu L (2013). Regulatory B cells in autoimmune 
diseases. Cell Mol Immunol. 10(2):122-32.  
 
Yuan S, Jiang T, Sun L, Zheng R, Ahat N, Zhang Y (2013). The role of bone 
marrow mesenchymal stem cells in the treatment of acute liver failure. 
2013:251846.  
 
Yurasov S, Wardemann H, Hammersen J (2005). Defective B cell tolerance 
checkpoints systemic lupus erythematosus. J Exp Med 201(5):703-­‐711. 
 
Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA (2004). LICHEN PLANUS: 
Gorsky M, Epstein JB. Natural and induced CD4+CD25+ cells educate 
CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and 
IL-10. J Immunol 172(9):5213-21.  
 
 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  
	  50	  	  
 
CURRICULUM VITAE 
                                                                             
                                                                             
                                                                                                                          
                                                                                                   
                                                                         
                                                                              
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  51	  	  
       	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	    
                                                             
   
                                                                                    
                                           
                                                                                    
                                             
	  52	  	  
                                                                                                                    
                                                                      
            
                                                         
                                                           
                                 
                                                    
                   
                             
